Recently, Labviva COO Aaron Miramontes sat down with Tech Company News to talk about what's new at Labviva.
SaaS Platform Labviva Supports Purchasing In The Field Of Life Sciences
Q: Could you provide our readers with a brief introduction to your company?
A: Labviva is SaaS platform that supports purchasing in the field of life sciences. It was founded in 2017 by me and other industry veterans, Siamak Barharloo (CEO) and Nicholas Rioux (CIO). The product itself integrates with enterprise procurement applications like SAP Ariba, Oracle Procurement Cloud, and JAGGEAR to provide a better purchasing experience for researchers. Labviva’s customers are research universities, pharmaceutical companies, and biotechnology firms.
It’s different than other offerings in the market in that the product supports the priorities of scientists by mapping products like reagents, chemicals, and instrumentation to scientific applications, techniques, and protocols. It also collects citations from peer reviewed journals and related documents, so that researchers can easily understand use cases.
Q: Any highlights on your recent announcement?
A: Labviva was excited to announce an $8 million USD series seed capital raise. This is our second major funding round, and investors placed a strong valuation on the company because of the ability to penetrate large some of the most well-known pharma, biotech, and research organizations in North America.
The funding will be used for further development of the platform with new product lines, including investment in operations and customer success platforms. In addition, we’re staffing up. Project managers, SCRUM masters, developers, and engineers who are interested in working out of our Boston office should check out labviva.com/jobs
Read the rest of the interview with Labviva COO Aaron Miramontes.